Table 1 Characteristics of patients with ischemic and hemorrhagic types of acute stroke compared to those without stroke
Characteristics | Total | No stroke | Stroke | p value |
|---|---|---|---|---|
N = 265 | N = 254 | N = 11 | ||
Age, years | 85.9 ± 6.5 | 85.8 ± 6.6 | 87.1 ± 4.5 | 0.398 |
Length of stay in acute care, days | 12.6 ± 7.7 | 12.7 ± 7.7 | 11.9 ± 7.8 | 0.645 |
Male sex | 114 (43.0%) | 109 (42.9%) | 5 (45.5%) | > 0.999 |
Help in ADL/IADL | 127 (47.9%) | 121 (47.6%) | 6 (54.5%) | 0.762 |
Mortality | 85 (32.1%) | 82 (32.3%) | 3 (27.3%) | > 0.999 |
Number of medications | 7.4 ± 4.1 | 7.4 ± 4.1 | 6.4 ± 3.0 | 0.286 |
Heart failure | 93 (36.5%) | 90 (36.9%) | 3 (27.3%) | 0.750 |
COPD | 30 (11.4%) | 27 (10.7%) | 3 (27.3%) | 0.117 |
Active smoking | 15 (5.7%) | 12 (4.8%) | 3 (27.3%) | 0.019 |
Kidney disease | 74 (28.2%) | 70 (27.9%) | 4 (36.4%) | 0.510 |
Diabetes under treatment | 63 (24.0%) | 60 (23.9%) | 3 (27.3%) | 0.728 |
Cognitive impairment | 134 (51.0%) | 127 (50.4%) | 7 (63.6%) | 0.540 |
Active neoplasia | 23 (8.8%) | 22 (8.8%) | 1 (9.1%) | > 0.999 |
History of coronary disease | 36 (13.6%) | 35 (13.8%) | 1 (9.1%) | > 0.999 |
History of stroke | 40 (15.2%) | 35 (13.8%) | 5 (45.5%) | 0.014 |
Atrial fibrillation | 61 (23.1%) | 58 (22.9%) | 3 (27.3%) | 0.719 |
Hypertension | 187 (70.8%) | 179 (70.8%) | 8 (72.7%) | > 0.999 |
Dyslipidemia | 91 (34.5%) | 84 (33.2%) | 7 (63.6%) | 0.051 |
PE or DVT | 6 (2.26%) | 6 (2.36%) | 0 | > 0.999 |
BMI, kg × m−2 | 24.8 ± 6.4 | 24.9 ± 6.4 | 20.7 ± 3.5 | 0.002 |
Asymptomatic | 22 (8.5%) | 19 (7.7%) | 3 (27.3%) | 0.056 |
Cough | 160 (61.5%) | 155 (62.2%) | 5 (45.5%) | 0.344 |
Dyspnea | 99 (38.1%) | 95 (38.2%) | 4 (36.4%) | > 0.999 |
Tiredness | 126 (48.5%) | 125 (50.2%) | 1 (9.1%) | 0.010 |
Falls | 30 (11.5%) | 28 (11.2%) | 2 (18.2%) | 0.369 |
Delirium | 53 (20.4%) | 49 (19.7%) | 4 (36.4%) | 0.242 |
FIM (18–126) | 71.8 ± 29.4 | 72.2 ± 29.7 | 62.1 ± 20.7 | 0.222 |
CIRS-G (0–56) | 19.1 ± 6.2 | 19.0 ± 6.3 | 20.3 ± 2.3 | 0.170 |
CFS ≥5 | 190 (80.9%) | 182 (80.5%) | 8 (88.9%) | > 0.999 |
PSI (0–395) | 126.1 ± 53.9 | 125.9 ± 54.7 | 130.7 ± 32.3 | 0.650 |
CURB-65 | 0.960 | |||
1–2 | 168 (63.6%) | 161 (63.6%) | 7 (63.6%) | |
3 | 86 (32.6%) | 82 (32.4%) | 4 (36.4%) | |
4–5 | 10 (3.8%) | 10 (4.0%) | 0 (0.0%) | |
FiO2, % | 26.4 ± 9.6 | 26.5 ± 9.6 | 24.2 ± 7.5 | 0.394 |
Lymphocytes, G/l | 1.2 ± 1.3 | 1.2 ± 1.3 | 1.0 ± 0.5 | 0.361 |
Pro-brain natriuretic peptide, pg/ml | 5904.0 ± 10,525.5 | 5129.4 ± 8216.0 | 25,657.8 ± 32,622.7 | 0.297 |
C-reactive protein, mg/l | 67.8 ± 72.0 | 66.4 ± 71.1 | 98.1 ± 89.1 | 0.270 |